|
|
||||||||
in Human B Lymphocytes: Possible Adjuvants for Th1 Responses1
Department of Pathophysiology, Division of Immunopathology, University of Vienna, Vienna, Austria
Oligodeoxynucleotides containing CpG motifs (CpG-ODN) represent
potential adjuvants for specific immunotherapy of type I allergies
because they foster Th1-like immune responses. However, previous work
has shown that CpG-ODN induce systemically active levels of TNF-
in
murine macrophages. The goal of the present study was to evaluate the
release of TNF-
in human cells by a CpG-ODN proven to induce Th1
immune responses in cells from atopic individuals and in mice. CpG-ODN
induced TNF-
in cells from atopic and healthy individuals. However,
the amounts were low, as determined by comparison with commonly used
Ags. Intracellular cytokine staining of PBMC revealed that
CpG-ODN-induced TNF-
derived exclusively from B lymphocytes. TNF-
contributed to the CpG-ODN-augmented proliferation and Ig synthesis in
PBMC, but was not involved in IFN-
synthesis. In conclusion, our
findings indicate that certain CpG-ODN induce low amounts of TNF-
in
human B lymphocytes and may therefore be used to modulate Th2-biased
immune responses in allergic patients.
This article has been cited by other articles:
![]() |
M. Gerstmayr, N. Ilk, I. Schabussova, B. Jahn-Schmid, E. M. Egelseer, U. B. Sleytr, C. Ebner, and B. Bohle A Novel Approach to Specific Allergy Treatment: The Recombinant Allergen-S-Layer Fusion Protein rSbsC-Bet v 1 Matures Dendritic Cells That Prime Th0/Th1 and IL-10-Producing Regulatory T Cells J. Immunol., December 1, 2007; 179(11): 7270 - 7275. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bohle, A. Breitwieser, B. Zwolfer, B. Jahn-Schmid, M. Sara, U. B. Sleytr, and C. Ebner A Novel Approach to Specific Allergy Treatment: The Recombinant Fusion Protein of a Bacterial Cell Surface (S-Layer) Protein and the Major Birch Pollen Allergen Bet v 1 (rSbsC-Bet v 1) Combines Reduced Allergenicity with Immunomodulating Capacity J. Immunol., June 1, 2004; 172(11): 6642 - 6648. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gursel, D. Verthelyi, I. Gursel, K. J. Ishii, and D. M. Klinman Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide J. Leukoc. Biol., May 1, 2002; 71(5): 813 - 820. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |